S151: COMBINATION OF LARGE SPLEEN AND LOW IN VIVO KINASE INHIBITION IS AN EARLY PREDICTOR OF INFERIOR MOLECULAR RESPONSE AND POOR OUTCOMES IN CHRONIC MYELOID LEUKAEMIA
Chung Kok,
Verity Saunders,
Phuong Dang,
Naranie Shanmuganathan,
Deborah White,
Susan Branford,
David Yeung,
Timothy Hughes
Affiliations
Chung Kok
1 SAHMRI (South Australian Health and Medical Research Institute), Precision Cancer Medicine, Adelaide, Australia
Verity Saunders
1 SAHMRI (South Australian Health and Medical Research Institute), Precision Cancer Medicine, Adelaide, Australia
Phuong Dang
1 SAHMRI (South Australian Health and Medical Research Institute), Precision Cancer Medicine, Adelaide, Australia
Naranie Shanmuganathan
1 SAHMRI (South Australian Health and Medical Research Institute), Precision Cancer Medicine, Adelaide, Australia
Deborah White
1 SAHMRI (South Australian Health and Medical Research Institute), Precision Cancer Medicine, Adelaide, Australia
Susan Branford
2 The University of Adelaide, Adelaide Medical School, Adelaide, Australia
David Yeung
1 SAHMRI (South Australian Health and Medical Research Institute), Precision Cancer Medicine, Adelaide, Australia
Timothy Hughes
1 SAHMRI (South Australian Health and Medical Research Institute), Precision Cancer Medicine, Adelaide, Australia
